查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1974266

经肠营养市场：依产品类型、剂型、年龄层及最终用户划分－2026-2032年全球预测

Enteral Feedings Market by Product Type, Form, Age Group, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，经肠营养市场价值将达到 23.1 亿美元，到 2026 年将成长至 24.5 亿美元，到 2032 年将达到 40.1 亿美元，复合年增长率为 8.17%。

主要市场统计数据
基准年 2025 23.1亿美元
预计年份：2026年 24.5亿美元
预测年份 2032 40.1亿美元
复合年增长率 (%) 8.17%

从策略观点看经肠营养趋势，有助于医疗保健决策者明确临床需求、供应链复杂性和相关人员的优先事项。

经肠营养已从专门的临床干预发展成为一个涵盖急性期护理、长期支持和家庭营养管理的跨学科领域。临床团队、采购经理、产品开发人员和支付方在诸如给药安全性、配方精准性、非专业人员易用性以及符合不断变化的监管要求等通用优先事项上开展了越来越多的合作。因此，经肠营养现在需要製定兼顾临床疗效、营运灵活性和患者体验的策略。

从急性照护到社区医疗保健，重塑经肠营养的实践和产品创新：技术、法规和护理服务模式的新趋势。

在经肠营养领域，技术、照护模式和监管方面正发生着融合性的变革，重新定义了产品的研发、采购和部署方式。泵浦的精确度、连接性和安全联锁等方面的技术进步减少了人为错误，并实现了远端监测；而配方科学则提供了更个人化的营养方案，以满足不同病患小组的代谢需求。因此，各相关人员需要重新思考如何将产品规格与临床工作流程结合，以实现临床价值和营运效率的双重提升。

评估美国在 2025 年实施的关税措施对筹资策略、价格透明度和临床采购惯例的累积影响。

美国2025年实施的关税措施，为经肠营养产品和製剂的采购及采购决策增添了新的复杂性。采购团队和製造商正在重新评估供应商所在地，重新谈判合同，并调整库存政策，以应对成本结构和物流计划的变化，同时降低跨境关税和海关程序波动带来的风险。这些调整正在重塑采购方法和供应商选择标准。

基于最终用户、产品、形式和年龄层的差异，对产品设计、通路策略和临床引入进行详细细分的影响。

市场区隔为产品设计和市场规划与临床工作流程和使用者需求的匹配提供了一个切实可行的观点。观察最终用户的差异可以发现，诊所、居家照护机构、医院（分为普通病房和加护病房）以及长期护理机构对供应系统、看护者培训和包装形式都有不同的要求。例如，在重症监护环境中，准确性和与监测系统的整合是优先考虑的因素，而在居家照护中，便携性、易用性和针对非医疗专业人员的看护者指导则更为重要。

区域需求因素和政策趋势（北美和南美、欧洲、中东和非洲以及亚太地区）影响分销、监管和临床实践。

区域趋势影响着监管预期、报销环境和分销物流，进而决定经肠营养产品的普及速度。在美洲，监管机构和大规模综合医疗保健系统正在推动连接器和标籤规则的标准化，而采购联盟则对供应商选择和合约条款施加重大影响。这为那些能够证明其产品除了临床疗效外还能带来成本节约的营运效益的製造商创造了机会。

主要製造商和经销商的竞争定位和策略倡议决定了产品系列、伙伴关係模式和市场进入通路。

经肠营养领域的竞争格局由差异化的产品系列、策略联盟以及跨市场品管系统的扩展能力所塑造。主要企业正从营养製剂拓展至整合输送系统，将帮浦、管路和连接装置结合，打造加值提案，进而提升临床安全性和管理透明度。这种设备和製剂能力的融合提高了新进入者的准入门槛，并凸显了临床证据、设备相容性和服务模式的重要性。

为产业领导者提供的实用策略建议：调整研发、商业模式和供应链韧性，以适应不断变化的临床和法规环境。

产业领导者应优先采取一系列切实可行的措施，使其商业策略与不断变化的临床需求和营运实际情况相适应。首先，投资于模组化产品架构，以便针对不同的医疗环境和病患群体快速进行配置变更。这种方法可以缩短产品变体的上市时间，同时简化监理申报流程。其次，透过采购多元化、在适当情况下采用近岸外包以及与贸易伙伴分担关税和物流风险的合约机制，增强供应链的韧性。这些措施可以提高供应的连续性，并降低单点故障的风险。

采用透明的调查方法，明确指出用于解释临床趋势、采购行为和产品创新的资料来源、定性访谈和分析框架。

本研究结合了质性访谈、文献回顾和有针对性的二手资料分析，以三角验证证据并从中得出可操作的见解。关键要素包括与急诊、长期照护和居家医疗机构的临床医生，以及综合医疗保健系统的采购经理和产品开发主管进行结构化对话。这些访谈用于检验观察结果，并了解真实环境中的决策标准。二手资料的选择并非基于单一资讯来源，而是为了提供有关监管指南、临床实践标准和技术趋势的背景资讯。

这是一份权威的综合分析报告，重点介绍了对临床医生、采购团队和行业高管至关重要的见解，旨在帮助他们了解经肠营养。

总之，经肠营养正处于转折点。在这个临床预期、供应链现实和监管要求交会的关键时刻，整合实证策略将带来成效。能够平衡产品创新与严格运作（尤其是在来源多元化、临床证据累积和数位化整合方面）的製造商和医疗系统领导者，将更有能力满足加护病房、普通病房、长期照护机构和家庭护理中复杂的营养需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章经肠营养市场：依产品类型划分

  • Bolus营养
  • 持续营养
  • 间歇性营养补充

第九章经肠营养市场：依形式划分

  • 液体
    • 浓缩型
    • 即用型
  • 粉末

第十章经肠营养市场：依年龄组别划分

  • 成人版
  • 老年人
  • 儿童

第十一章经肠营养市场：依最终用户划分

  • 诊所
  • 居家照护
  • 医院
    • 普通病房
    • 加护病房
  • 长期照护机构

第十二章经肠营养市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章经肠营养市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章经肠营养市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国经肠营养市场

第十六章：中国经肠营养市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Amsino International Inc
  • Applied Medical Technology Inc
  • Avanos Medical Inc
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • CONMED Corporation
  • Cook Medical LLC
  • Danone SA
  • Fresenius SE & Co. KGaA
  • Glanbia Plc
  • Global Health Products Inc
  • Hormel Foods Corporation
  • ICU Medical Inc
  • Kimberly-Clark Corporation
  • Medline Industries LP
  • Meiji Holdings Co., Ltd.
  • Moog Inc
  • Nestle SA
  • Perrigo Company PLC
  • Reckitt Benckiser Group PLC
  • Vygon SA
Product Code: MRR-3F575F196088

The Enteral Feedings Market was valued at USD 2.31 billion in 2025 and is projected to grow to USD 2.45 billion in 2026, with a CAGR of 8.17%, reaching USD 4.01 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.31 billion
Estimated Year [2026] USD 2.45 billion
Forecast Year [2032] USD 4.01 billion
CAGR (%) 8.17%

A strategic orientation to enteral feeding dynamics that frames clinical demand, supply chain complexity, and stakeholder priorities for healthcare decision-makers

Enteral feeding has evolved from a specialized clinical intervention to a multidisciplinary field spanning acute care, long-term support, and home-based nutrition management. Clinical teams, procurement leads, product developers, and payers increasingly converge around shared priorities: safety of administration, formulation precision, ease of use for non-specialists, and adherence to evolving regulatory expectations. Consequently, enteral feeding now demands strategies that balance clinical efficacy with operational resilience and patient experience.

This introduction frames the principal forces shaping contemporary enteral nutrition. The narrative begins with clinical imperatives in intensive care and chronic care environments, then moves to the operational drivers in hospitals and home care settings that influence procurement and product selection. Finally, it profiles the cross-cutting themes-connectivity and digital workflows, supply chain continuity, and sustainability-that are central to strategic decision-making. By establishing this orientation, the reader gains a concise but comprehensive backdrop for subsequent sections that analyze transformational shifts, policy effects, segmentation dynamics, regional considerations, competitive behaviors, and recommended actions for stakeholders.

Emerging technological, regulatory and care-delivery shifts reshaping enteral nutrition practice and product innovation across acute and community care settings

The enteral feeding landscape is experiencing convergent shifts in technology, care delivery models, and regulatory scrutiny that are redefining how products are developed, procured, and deployed. Technological advances in pump accuracy, connectivity, and safety interlocks are reducing human error and enabling remote monitoring, while formulation science is delivering more tailored nutrient profiles to address metabolic needs across patient groups. As a result, stakeholders must rethink product specifications and integration with clinical workflows to capture both clinical value and operational efficiencies.

Concurrently, care delivery is decentralizing; greater emphasis on home care and early hospital discharge has elevated the importance of usability, packaging formats, and caregiver training. This transition is accompanied by intensified regulatory attention to labeling, traceability, and device-feeding system compatibility, prompting manufacturers to invest in compliance and post-market surveillance. Together, these dynamics favor companies that can align robust clinical evidence with modular product portfolios and agile supply chains, enabling faster adoption in settings ranging from intensive care units to community-based clinics.

Assessing the cumulative consequences of recent United States tariff measures introduced in 2025 on sourcing strategies, pricing transparency, and clinical procurement practices

The tariff measures introduced by the United States in 2025 have introduced a new layer of complexity into procurement and sourcing decisions for enteral feeding supplies and formulations. Procurement teams and manufacturers are responding to altered cost structures and logistical timelines by re-evaluating supplier footprints, renegotiating contracts, and recalibrating inventory policies to mitigate exposure to cross-border duties and customs variability. In turn, these adaptations are reshaping procurement playbooks and vendor selection criteria.

Operationally, the tariff environment has accelerated interest in supply diversification and nearshoring strategies. Many organizations are assessing dual-sourcing models that reduce single-vendor dependence while preserving access to specialty inputs such as nutrient concentrates and packaging substrates. In parallel, purchasing groups and hospital systems are placing greater emphasis on contract clauses that address tariff pass-throughs, lead-time guarantees, and dispute resolution. Taken together, these shifts underscore the strategic premium on supply chain agility and commercial arrangements that can absorb or deflect the operational impacts of tariff policy changes.

Granular segmentation-driven implications for product design, channel strategy, and clinical adoption informed by end user, product, form, and age group distinctions

Segmentation offers a practical lens to align product design and go-to-market plans with clinical workflows and user needs. When observed through end user distinctions, clinics, home care environments, hospitals-subdivided into general wards and intensive care units-and long term care facilities each impose distinct requirements on delivery systems, caregiver training, and packaging formats. For example, intensive care settings prioritize precision and integration with monitoring systems, whereas home care emphasizes portability, simplicity, and caregiver instructions tailored for non-clinician use.

Product type further refines value propositions across bolus feeding, continuous feeding, and intermittent feeding, each demanding unique pump features, tubing sets, and formulation stability profiles. Form considerations likewise influence logistics and user preference: products available as liquid and powder present trade-offs between immediate readiness and transport efficiency, and the liquid category in particular divides into concentrate and ready-to-use options that change clinical workflow and storage needs. Age group segmentation spanning adult, geriatric, and pediatric cohorts requires tailored nutrient profiles, administration devices, and labeling to ensure safety and adherence. Synthesizing these dimensions helps manufacturers prioritize SKU rationalization, devise targeted clinical education, and optimize channel strategies for distinct care environments.

Regional demand drivers and policy vectors across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence distribution, regulation, and clinical practice

Regional dynamics shape regulatory expectations, reimbursement environments, and distribution logistics, which in turn determine the cadence of adoption for enteral feeding products. Across the Americas, regulatory authorities and large integrated health systems often drive standardization of connectors and labeling conventions, while procurement consortia exert notable influence on supplier selection and contract terms. This creates opportunities for manufacturers who can demonstrate operational savings alongside clinical outcomes.

In Europe, Middle East & Africa, heterogeneity in regulatory pathways and health system architectures requires adaptable market entry strategies and tiered product offerings. Manufacturers must navigate divergent national standards and reimbursement models, and they benefit from localized clinical evidence generation to support adoption. Asia-Pacific markets are characterized by rapid uptake of home care services and investment in domestic production capabilities; this region's emphasis on local manufacturing and strategic partnerships makes it vital for companies to balance global product consistency with regional customization. Across all regions, attention to logistics resilience, regulatory alignment, and culturally appropriate patient and caregiver education remains essential for sustained market access and clinical uptake.

Competitive positioning and strategic moves by leading manufacturers and distributors that determine product portfolios, partnership models, and routes to market

Competitive dynamics in the enteral feeding space are shaped by differentiated portfolios, strategic partnerships, and the ability to scale quality systems across markets. Leading players are extending beyond nutrition formulations into integrated delivery systems, combining pumps, tubing, and connectivity features to create bundled value propositions that address clinical safety and administrative transparency. This convergence of device and formulation capabilities raises the bar for newcomers and underscores the importance of clinical evidence, device compatibility, and service models.

Market leaders are also investing in specialized formulations and supply chain certification to meet stringent clinical and regulatory requirements. In parallel, a cohort of agile manufacturers and regional distributors is capitalizing on niche opportunities-such as pediatric-specific formulations, geriatric-friendly packaging, or low-resource setting solutions-by offering tailored products and localized support. Strategic alliances with clinical institutions, technology vendors, and logistics partners are increasingly important for scaling post-market surveillance, training programs, and digital tools that improve adherence and outcomes. Ultimately, competitive advantage accrues to organizations that integrate product excellence with demonstrable operational support and evidence-based clinical engagement.

Practical strategic recommendations for industry leaders to align R&D, commercial models, and supply chain resilience with evolving clinical and regulatory realities

Industry leaders should prioritize a set of pragmatic actions to align commercial strategy with evolving clinical needs and operational realities. First, invest in modular product architectures that allow rapid configuration for different care settings and patient cohorts; this approach reduces time to market for variants while simplifying regulatory submissions. Second, strengthen supply chain resilience through diversified sourcing, nearshoring where appropriate, and contractual mechanisms that share tariff and logistics risk with trading partners. These measures enhance continuity of supply and reduce exposure to single-point failures.

Third, build clinical evidence programs that extend beyond controlled trials to include real-world data from home care and long term care settings; this will support payer conversations and clinical adoption. Fourth, embed connectivity and usability into product development, ensuring that devices and formulations integrate with electronic health records and remote monitoring platforms. Finally, develop targeted commercial models that reflect regional reimbursement practices and stakeholder incentives, and complement them with robust training and post-market support to drive adoption and ensure safe administration.

Transparent methodology outlining data sources, qualitative interviews, and analytical frameworks used to interpret clinical trends, procurement behaviors, and product innovation

The research approach combined qualitative interviews, document review, and targeted secondary analysis to triangulate evidence and surface actionable insights. Primary engagements included structured conversations with clinicians across acute, long term, and home care settings, procurement leaders from integrated health systems, and product development executives; these interviews were used to corroborate observational findings and understand decision criteria in real-world settings. Secondary sources were selected to provide context on regulatory guidance, clinical practice standards, and technology trends without relying on single-source narratives.

Analytical frameworks applied in the study included value-chain mapping to identify supply risks, stakeholder journey analysis to highlight pain points in administration and procurement, and capability benchmarking to assess supplier readiness across quality systems and evidence generation. Throughout the process, iterative validation workshops were held with subject-matter experts to refine interpretations and ensure that conclusions reflected operational realities. Transparency around limitations and assumptions was maintained, and appendices document interview protocols, inclusion criteria, and the audit trail for qualitative coding.

Conclusive synthesis highlighting priority implications for clinicians, procurement teams, and industry executives seeking to navigate the enteral feeding landscape

In conclusion, enteral feeding is at an inflection point where clinical expectations, supply chain realities, and regulatory demands converge to reward integrated, evidence-driven strategies. Manufacturers and health system leaders that couple product innovation with operational rigor-especially in supply diversification, clinical evidence generation, and digital integration-will be better positioned to meet the complex needs of intensive care, general wards, long term care, and home-based administration.

Moving forward, stakeholders should treat adaptability as a core organizational capability: whether responding to policy changes that affect cross-border trade or tailoring formulations and delivery systems to distinct patient populations, the most resilient organizations will be those that translate insights into pragmatic actions across R&D, procurement, and clinical engagement. By doing so, they can improve safety, enhance patient experience, and sustain commercial performance in a market that increasingly prizes interoperability, traceability, and demonstrable clinical value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Enteral Feedings Market, by Product Type

  • 8.1. Bolus Feeding
  • 8.2. Continuous Feeding
  • 8.3. Intermittent Feeding

9. Enteral Feedings Market, by Form

  • 9.1. Liquid
    • 9.1.1. Concentrate
    • 9.1.2. Ready To Use
  • 9.2. Powder

10. Enteral Feedings Market, by Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Enteral Feedings Market, by End User

  • 11.1. Clinics
  • 11.2. Home Care
  • 11.3. Hospitals
    • 11.3.1. General Wards
    • 11.3.2. Intensive Care Units
  • 11.4. Long Term Care Facilities

12. Enteral Feedings Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Enteral Feedings Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Enteral Feedings Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Enteral Feedings Market

16. China Enteral Feedings Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Amsino International Inc
  • 17.7. Applied Medical Technology Inc
  • 17.8. Avanos Medical Inc
  • 17.9. B. Braun Melsungen AG
  • 17.10. Baxter International Inc
  • 17.11. Becton Dickinson and Company
  • 17.12. Boston Scientific Corporation
  • 17.13. Cardinal Health Inc
  • 17.14. CONMED Corporation
  • 17.15. Cook Medical LLC
  • 17.16. Danone S.A.
  • 17.17. Fresenius SE & Co. KGaA
  • 17.18. Glanbia Plc
  • 17.19. Global Health Products Inc
  • 17.20. Hormel Foods Corporation
  • 17.21. ICU Medical Inc
  • 17.22. Kimberly-Clark Corporation
  • 17.23. Medline Industries LP
  • 17.24. Meiji Holdings Co., Ltd.
  • 17.25. Moog Inc
  • 17.26. Nestle S.A.
  • 17.27. Perrigo Company PLC
  • 17.28. Reckitt Benckiser Group PLC
  • 17.29. Vygon S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENTERAL FEEDINGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENTERAL FEEDINGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY BOLUS FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY BOLUS FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY BOLUS FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONTINUOUS FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONTINUOUS FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONTINUOUS FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTERMITTENT FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTERMITTENT FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTERMITTENT FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONCENTRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONCENTRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CONCENTRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY READY TO USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY READY TO USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY READY TO USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GENERAL WARDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GENERAL WARDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GENERAL WARDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTENSIVE CARE UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTENSIVE CARE UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY INTENSIVE CARE UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LONG TERM CARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LONG TERM CARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY LONG TERM CARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 121. GCC ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GCC ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. GCC ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 124. GCC ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 125. GCC ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GCC ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 142. G7 ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. G7 ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. G7 ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 145. G7 ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 146. G7 ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. G7 ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. NATO ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NATO ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NATO ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 153. NATO ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. NATO ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ENTERAL FEEDINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA ENTERAL FEEDINGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA ENTERAL FEEDINGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA ENTERAL FEEDINGS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA ENTERAL FEEDINGS MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA ENTERAL FEEDINGS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA ENTERAL FEEDINGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA ENTERAL FEEDINGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)